Jeffrey L. Dage

Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders

Sebastian Palmqvist, Shorena Janelidze, Yakeel T. Quiroz et al. · JAMA · 2020 · 1.4K citations · Full text

Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia

Shorena Janelidze, Niklas Mattsson, Sebastian Palmqvist et al. · Nature Medicine · 2020 · 1.2K citations

Neurodegenerative Diseases, Plasma P-tau181, Alzheimer's Disease +14

Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration

Elisabeth H. Thijssen, Renaud La Joie, Amy Wolf et al. · Nature Medicine · 2020 · 767 citations · Full text

Frontotemporal Lobar Degeneration, Neurodegenerative Diseases, Alzheimer's Disease +13

Plasma phospho‐tau181 increases with Alzheimer's disease clinical severity and is associated with tau‐ and amyloid‐positron emission tomography

Michelle M. Mielke, Clinton E. Hagen, Jing Xu et al. · Alzheimer s & Dementia · 2018 · 643 citations

Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study

Elisabeth H. Thijssen, Renaud La Joie, Amelia Strom et al. · The Lancet Neurology · 2021 · 538 citations · Full text

Frontotemporal Lobar Degeneration, Neurodegenerative Diseases, Alzheimer's Disease +14